Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2024 Financial Results [Yahoo! Finance]
Cryo-Cell International, Inc. (CCEL)
NASDAQ:AMEX Investor Relations:
cryo-cell.com/investor-relations
Company Research
Source: Yahoo! Finance
American LLC Symbol: CCEL) (the "Company"), the world's first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended August 31, 2024. Financial Results Revenue Consolidated revenues for the third quarter of fiscal 2024 were $8.07 million compared to $7.87 million for the third quarter of fiscal 2023. Net Income The Company reported net income for the three months ended August 31, 2024 of $1.05 million, or $0.13 per basic share and diluted share, compared to net income of $681,000, or $0.08 per basic and diluted share for the three months ended August 31, 2023. During the three months ended August 31, 2024, gains on marketable securities was $522,000 compared to $93,000 for the three months ended August 31, 2023. David Portnoy, Chairman of the Board and Co-CEO, commented, "As previously reported, the Company is exploring strategic alternatives to maximize shareholder value and that process remains underway. The
Show less
Read more
Impact Snapshot
Event Time:
CCEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CCEL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CCEL alerts
High impacting Cryo-Cell International, Inc. news events
Weekly update
A roundup of the hottest topics
CCEL
News
- Cord Blood Banking Leader Cryo-Cell Declares Initiation of Regular Quarterly Cash DividendBusiness Wire
- Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2024 Financial ResultsBusiness Wire
- Stem Cell Umbilical Cord Blood Market Report 2024, with Profiles of Cryo-Cell, Cordlife, ViaCord, CryoHoldco, LifeCell, StemCyte, Celularity Cryo-Save and Vita 34 [Yahoo! Finance]Yahoo! Finance
CCEL
Sec Filings
- 11/14/24 - Form 4
- 11/12/24 - Form S-8
- 10/31/24 - Form 4
- CCEL's page on the SEC website